Welcome to our dedicated page for VISTEON SEC filings (Ticker: VC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Visteon Corporation filings document the regulatory record for an automotive electronics supplier focused on cockpit systems, vehicle software, and EV architecture solutions. Recent 8-K reports include results of operations and Regulation FD disclosures for quarterly and annual performance, product-launch activity, new business wins, share repurchases, dividends, and related exhibits.
Other filings cover capital-structure and governance matters, including amendments to the company's credit agreement, revolving and term loan facilities, subsidiary guarantor arrangements, definitive proxy disclosures, executive compensation, pay-versus-performance information, and shareholder voting matters.
Robert R. Vallance, Senior Vice President of Visteon Corporation (VC), reported a sale of 2,000 shares of the company's common stock on 08/13/2025 at a price of $120 per share. After the transaction, he beneficially owned 18,838 shares directly. The filing states the trades were executed under a Rule 10b5-1 trading plan that Vallance adopted on March 5, 2025. The Form 4 was signed on behalf of the reporting person on 08/14/2025. The report identifies Vallance as an officer (Senior Vice President) and was filed as an individual Form 4.
Visteon Corporation received a Schedule 13G/A (Amendment No. 2) disclosing that American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research beneficially own 2,222,551 shares of common stock, representing 8.2% of the class. The cover pages report sole voting power of 2,173,962 shares and sole dispositive power of 2,222,551 shares. The filers state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The position is reported as of 06/30/2025, the filing is signed 08/14/2025, and an exhibit records consent to the joint filing.
VISTEON CORPORATION insider disclosure reports a planned sale of 2,000 common shares through Fidelity Brokerage Services, with an aggregate market value of $240,000 and an approximate sale date of 08/13/2025. The notice lists 27,276,339 shares outstanding and identifies NASDAQ as the exchange.
The filing shows the securities to be sold were acquired as restricted stock vesting on 01/11/2021 (862 shares) and 02/15/2023 (1,138 shares), with payment characterized as compensation. It also discloses recent sales by the same person: 4,000 shares on 06/05/2025 (gross proceeds $329,840) and 2,000 shares on 07/02/2025 (gross proceeds $200,300).
By signing the notice, the seller represents they do not possess any undisclosed material adverse information. Broker details are recorded as Fidelity Brokerage Services LLC.
Victory Capital Management, Inc. filed Amendment No. 1 to a Schedule 13G disclosing beneficial ownership of 1,044,633 shares of Visteon Corp common stock, representing 3.83% of the class. The filing reports 995,979 shares as sole voting power and 1,044,633 shares as sole dispositive power, with the event date listed as 06/30/2025 and the statement signed on 08/08/2025.
The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control. No group affiliations, acquisitions, or other material transactions are disclosed in this amendment.
Visteon Corp (VC) Form 4: SVP & Chief Legal Officer Brett D. Pynnonen reported selling 1,200 common shares on 08/01/2025 in two open-market transactions at $109.86 and $109.85 per share, for proceeds of roughly $132k. Following the sales, his direct beneficial ownership fell from 12,967 to 11,767 shares.
No derivative transactions were reported and no Rule 10b5-1 plan box was indicated. The filing reflects routine insider activity with no accompanying narrative or material company developments.
Visteon Corp. (VC) has filed a Form 144 indicating an insider’s intent to sell up to 1,200 common shares through Fidelity Brokerage on or after 01 Aug 2025. The proposed sale is valued at $131,829, based on the filing’s reference price, and represents roughly 0.004% of the 27.28 million shares outstanding. The shares originated from restricted-stock vesting on 15 Feb 2023 and were received as compensation; no shares have been sold by this filer in the prior three months.
- No material adverse information is claimed by the seller, as affirmed in the signature section.
- The notice does not amend earnings guidance, announce operational events, or affect capital structure; its sole purpose is to comply with Rule 144 disclosure for a routine, small-scale disposition.
Given the limited size relative to float, market impact should be minimal, though investors often monitor insider activity as a sentiment indicator.
Visteon Corp. (VC) filed a Form 144 indicating an insider’s intent to sell 710 common shares through Fidelity Brokerage Services on or after 28 Jul 2025. The proposed sale carries an aggregate market value of ≈$81.7 K, based on the price prevailing at the time of filing. The shares stem from restricted-stock vesting on 15 Feb 2023 and are being sold for the account of the award recipient.
The 710 shares represent ≈0.003 % of Visteon’s 27.28 M shares outstanding and therefore do not materially alter public float or insider ownership levels. No other sales were reported in the past three months, and the filer attests to the absence of undisclosed adverse information.
Form 144 is a notice only; it does not obligate the sale and provides no financial performance data or guidance. Given the negligible size relative to market capitalization, the filing is unlikely to affect valuation or trading dynamics.